Home › Valeant Pharma expects 3Q revenue to top forecasts
 

Keywords :   


Valeant Pharma expects 3Q revenue to top forecasts

2014-09-25 00:03:23| Biotech - Topix.net

Shares of Valeant Pharmaceuticals International Inc. climbed Wednesday after the Canadian drugmaker said it expects market share gains in most of its businesses and that its third-quarter revenue will top forecasts. The drugmaker also said it expects 10 percent growth from the established business of its contact lens maker Bausch + Lomb, a target of criticism in Valeant's on-going takeover battle with Botox-maker Allergan Inc. Allergan has rebuffed several takeover bids from Valeant over the past few months, the latest amounting to about $53 billion.

Tags: top revenue expects forecasts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Public Advisory Number 18A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07Atlantic Tropical Weather Outlook
03.07Benefits of benchmarking in the pork industry
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 18
More »